Literature DB >> 12450171

Economic benefit of tonsillectomy in adults with chronic tonsillitis.

Neil Bhattacharyya1, Lynn J Kepnes.   

Abstract

To determine the economic impact of adult chronic tonsillitis and the economic improvement from adult tonsillectomy, we studied patients who underwent adult tonsillectomy for chronic tonsillitis with the Glasgow Benefit Inventory and a questionnaire for disease severity parameters before and after tonsillectomy. The economic impact of chronic tonsillitis and adult tonsillectomy were computed with a break-even time analysis model. Eighty-three adult patients (average age, 27.3 years) completed the study with an average duration of follow-up of 37.7 months. The patients exhibited a mean improvement in quality of life of +27.54 +/- 4.63 after tonsillectomy according to the Glasgow Benefit Inventory. In the 12 months following the procedure, tonsillectomy resulted in yearly mean decreases in number of weeks on antibiotics by 5.9 weeks, number of workdays missed because of tonsillitis by 8.7 days, and physician visits for tonsillitis by 5.3 visits. In considering the medical costs of tonsillectomy only, the break-even point was found to be 12.7 years, whereas considering the overall economic impact of tonsillectomy resulted in a break-even point of 2.3 years after the procedure. We conclude that tonsillectomy results in significant improvement in quality of life, decreases health-care utilization, and diminishes the economic burden of chronic tonsillitis in the adult patient population.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12450171     DOI: 10.1177/000348940211101106

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  19 in total

1.  Recurrent tonsillitis in adults: quality of life after tonsillectomy.

Authors:  Götz Senska; Stefanie Ellermann; Stefan Ernst; Hildegard Lax; Philipp Dost
Journal:  Dtsch Arztebl Int       Date:  2010-09-10       Impact factor: 5.594

2.  Long-Term Results From Tonsillectomy in Adults.

Authors:  Götz Senska; Halil Atay; Carolin Pütter; Philipp Dost
Journal:  Dtsch Arztebl Int       Date:  2015-12-11       Impact factor: 5.594

3.  [Outcome after tonsillectomy for chronic tonsillitis].

Authors:  I Baumann
Journal:  HNO       Date:  2005-05       Impact factor: 1.284

4.  [Chronic rhinosinusitis. Subjective assessment of benefit 1 year after functional endonasal sinus surgery].

Authors:  I Baumann; G Blumenstock; C Klingmann; M Praetorius; P K Plinkert
Journal:  HNO       Date:  2007-11       Impact factor: 1.284

5.  Short-term outcomes of tonsillectomy in adult patients with recurrent pharyngitis: a randomized controlled trial.

Authors:  Timo Koskenkorva; Petri Koivunen; Markku Koskela; Onni Niemela; Aila Kristo; Olli-Pekka Alho
Journal:  CMAJ       Date:  2013-04-02       Impact factor: 8.262

6.  Medical and surgical treatment in divers with chronic rhinosinusitis and paranasal sinus barotrauma.

Authors:  Theodoros Skevas; Ingo Baumann; Thomas Bruckner; Nick Clifton; Peter K Plinkert; Christoph Klingmann
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-09-08       Impact factor: 2.503

Review 7.  [Validated instruments to measure quality of life in patients with chronic rhinosinusitis].

Authors:  I Baumann
Journal:  HNO       Date:  2009-09       Impact factor: 1.284

8.  Benefit from tonsillectomy in adult patients with chronic tonsillitis.

Authors:  Ingo Baumann; Hanka Kucheida; Gunnar Blumenstock; Ilse M Zalaman; Marcus M Maassen; Peter K Plinkert
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-02-21       Impact factor: 2.503

9.  Clinical practice guideline: tonsillitis II. Surgical management.

Authors:  Jochen P Windfuhr; Nicole Toepfner; Gregor Steffen; Frank Waldfahrer; Reinhard Berner
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-16       Impact factor: 2.503

10.  Normative tonsillectomy outcome inventory 14 values as a decision-making tool for tonsillectomy.

Authors:  Michaela Plath; Matthias Sand; Philippe A Federspil; Peter K Plinkert; Ingo Baumann; Karim Zaoui
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-09-22       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.